{
    "2020-12-16": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Novartis' Entresto Gets FDA Panel Nod for Expanded Use",
                "features": {
                    "keywords": [
                        "Entresto",
                        "FDA",
                        "Panel Nod",
                        "Expanded Use"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal",
                "features": {
                    "keywords": [
                        "Adcom Backing",
                        "Sio Gene Data",
                        "IPOs",
                        "BioNTech",
                        "China Vaccine Supply Deal"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Novartis announces positive FDA Advisory Committee recommendation for use of EntrestoÂ® to treat patients with HFpEF",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA Advisory Committee",
                        "Entresto",
                        "HFpEF"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}